DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Rebif
Interferon beta-1a
Interferon beta-1a (also interferon beta-1-alpha) is a drug in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells while Interferon beta-1b is produced in modified E. coli. Interferons have been shown to have about a 18–38% reduction in the rate of MS relapses, and to slow the progression of disability in MS patients. None of the products on the market is a cure, but patients today who start early on Interferons may beneficially alter the natural course of the disease. There are two principal competitors in the market for this drug and one biosimilar one: Avonex Rebif CinnoVex
Rebif - List of case studies
- Multiple Sclerosis_2
-
beta-1b (Betaseron) and interferon beta-1a (Avonex, Rebif) are genetically engineered copies of proteins that occur naturally. They ... is injected subcutaneously every other day. Rebif is injected subcutaneously three times a week. Avonex ...
- Drugs
-
Ranidil Rapamycin Rate slowing drugs Rebif Rebif (interferon beta 1a) Recombinant FSH Recombinant human Growth ...
- Multiple Sclerosis
-
therapy includes Avonex, Betaseron, Copaxone, and Rebif. These medications decrease the progression of multiple sclerosis through ... AVONEX, Interferon beta-1a, Avonex, Betaseron, Copaxone, Rebif, Intravenous steroids, methylprednisolone, Solumedrol, interferons, ...
- Multiple sclerosis in remission under Avonex treatment
-
includes Avonex , Betaseron , Copaxone , and Rebif . These medications decrease the progression of multiple sclerosis ... AVONEX (Interferon beta-1a), Avonex, Betaseron, Copaxone, Rebif, Methylprednisolone (Solumedrol) (Case ...
- Multiple Sclerosis (MS)
-
He was offered several immunomodulatory treatment options: Rebif, Betaferon and Copaxone, and asks about their pros, cons and ... immunomodulatory treatment , with the following options: Rebif, Betaferon and Copaxone. ...